Liothyronine (t3) Cap recalls
The FDA has published 1 recall involving Liothyronine (t3) Cap since 2020. The latest was reported on 5 Feb 2020. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 Feb 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why liothyronine (t3) cap is recalled
Companies
By year
All liothyronine (t3) cap recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Liothyronine (T3) 80 mcg SR cap recalled by MPRX | Mprx | Other | TX |
Should you stop taking Liothyronine (t3) Cap?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.